These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 26501927)

  • 1. Evolving Knowledge in Pharmacologic Treatments of Age-Related Macular Degeneration.
    Soubrane Daguet G; Risard-Gasiorowski S; Massamba N
    Dev Ophthalmol; 2016; 55():1-6. PubMed ID: 26501927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-macular degeneration agents.
    Rothen M; Jablon E; Monares G; Fontal MR; Alfaro DV
    Ophthalmol Clin North Am; 2005 Dec; 18(4):561-7. PubMed ID: 16314219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Vascular Endothelial Growth Factor Injection for Exudative Age-related Macular Degeneration in Patients with Vitreo-Macular Traction.
    Querques G
    Am J Ophthalmol; 2009 Feb; 147(2):375-6; author reply 376-7. PubMed ID: 19166716
    [No Abstract]   [Full Text] [Related]  

  • 4. Emerging therapeutic options in age-related macular degeneration.
    Querques G; Capuano V; Frascio P; Bandello F; Souied EH
    Ophthalmic Res; 2015; 53(4):194-9. PubMed ID: 25871486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting VEGF-A to treat cancer and age-related macular degeneration.
    Ferrara N; Mass RD; Campa C; Kim R
    Annu Rev Med; 2007; 58():491-504. PubMed ID: 17052163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal pigment epithelial tears and the management of exudative age-related macular degeneration.
    Barkmeier AJ; Carvounis PE
    Semin Ophthalmol; 2011 May; 26(3):94-103. PubMed ID: 21609221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreous in Age-Related Macular Degeneration Therapy--The Medium Is the Message.
    Sebag J
    Retina; 2015 Sep; 35(9):1715-8. PubMed ID: 26312447
    [No Abstract]   [Full Text] [Related]  

  • 8. Age-related macular degeneration and cardiovascular disease in the era of anti-vascular endothelial growth factor therapies.
    Wong TY
    Am J Ophthalmol; 2009 Sep; 148(3):327-9. PubMed ID: 19703607
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination therapy for age-related macular degeneration.
    Patel S
    Retina; 2009 Jun; 29(6 Suppl):S45-8. PubMed ID: 19553801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Review and expert opinion in age related macular degeneration. Focus on the pathophysiology, angiogenesis and pharmacological and clinical data].
    Weber M; Sennlaub F; Souied E; Cohen SY; Béhar-Cohen F; Milano G; Tadayoni R
    J Fr Ophtalmol; 2014 Sep; 37(7):566-79. PubMed ID: 25190312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-angiogenic drugs].
    Sato Y
    Nihon Rinsho; 2010 Oct; 68(10):1825-9. PubMed ID: 20954324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts.
    Noël A; Jost M; Lambert V; Lecomte J; Rakic JM
    Trends Mol Med; 2007 Aug; 13(8):345-52. PubMed ID: 17644433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for inhibiting vascular endothelial growth factor.
    Kaiser PK
    Retina; 2009 Jun; 29(6 Suppl):S15-7. PubMed ID: 19553789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New drug treatment for age-related macular degeneration].
    Stefánsson E; la Cour M; Helgadóttir G; Sigurdsson H; Jónasson F
    Laeknabladid; 2007 Apr; 93(4):299-301. PubMed ID: 17460341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation therapy for neovascular age-related macular degeneration.
    Kishan AU; Modjtahedi BS; Morse LS; Lee P
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):583-97. PubMed ID: 22975610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective audit of exudative age-related macular degeneration: 12-month outcomes in treatment-naive eyes.
    Gillies MC; Walton R; Simpson JM; Arnold JJ; Guymer RH; McAllister IL; Hunyor AP; Essex RW; Morlet N; Barthelmes D;
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5754-60. PubMed ID: 23821201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination angiostatic therapies: current status.
    Peyman GA; Fiscella R; Conway M
    Retina; 2009 Jun; 29(6 Suppl):S18-20. PubMed ID: 19553790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor biology: clinical implications for ocular treatments.
    Bhisitkul RB
    Br J Ophthalmol; 2006 Dec; 90(12):1542-7. PubMed ID: 17114590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Unspecific effects of certain siRNA molecules used in the treatment of age related macular degeneration].
    Ebbesen M; Bek T; Pedersen FS; Jensen TG
    Ugeskr Laeger; 2010 Sep; 172(36):2457-9. PubMed ID: 20825735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystoid macular degeneration in exudative age-related macular degeneration.
    Querques G; Coscas F; Forte R; Massamba N; Sterkers M; Souied EH
    Am J Ophthalmol; 2011 Jul; 152(1):100-107.e2. PubMed ID: 21570056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.